Skip to main

News

Delhi High Court Cancels DECA-NEUROPHEN Mark, Upholds Reckitt NUROFEN Rights

4 October 2026

The Delhi High Court has allowed Reckitt and Colman Overseas Health Limited's appeal and ordered removal of the DECA-NEUROPHEN trademark from the Indian register.

Justice Tejas Karia ruled that the mark DECA-NEUROPHEN, sought by Ind Swift Limited for Class 5 pharmaceutical preparations, is deceptively similar to Reckitt's NUROFEN mark, which has been registered since 1983 for ibuprofen-containing products. The court emphasized a stricter approach to similarity assessments for medicinal marks.

The Trade Marks Registry had dismissed Reckitt's opposition in February 2024 and permitted the registration to proceed. The High Court set aside that order, directing the registry to cancel the impugned mark under relevant provisions of the Trade Marks Act, 1999.

The decision restores priority to the senior NUROFEN registration and underscores judicial scrutiny of pharmaceutical trademark conflicts.

Sources: https://www.bwlegalworld.com/article/delhi-hc-sets-aside-registration-of-deca-neurophen-upholds-reckitt-s-nurofen-rights-585762 https://www.bwlegalworld.com/

Share